Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? - 15/12/17
Doi : 10.1016/j.clinre.2017.03.006
Lucia Taramasso a, ⁎ 
, Elena Ricci b, Benedetto Maurizio Celesia c, Paolo Bonfanti d, Tiziana Quirino e, Nicola Squillace f, Laura Ambra Nicolini a, Paolo Maggi g, Canio Martinelli h, Giuseppe Vittorio De Socio i, Antonio Di Biagio a
, Elena Ricci b, Benedetto Maurizio Celesia c, Paolo Bonfanti d, Tiziana Quirino e, Nicola Squillace f, Laura Ambra Nicolini a, Paolo Maggi g, Canio Martinelli h, Giuseppe Vittorio De Socio i, Antonio Di Biagio aon behalf CISAI Study Group
a University of Genova (DISSAL), Infectious Diseases Clinic, IRCCS AOU San Martino-IST, Largo R. Benzi, 10, 16132 Genova, Italy
b Epi2004, Luigi Sacco Hospital, Milano, Italy
c Infectious Diseases Unit, University of Catania, ARNAS (Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione) Garibaldi, Catania, Italy
d Infectious Diseases Unit, A. Manzoni Hospital, Lecco, Italy
e Unit of Infectious Diseases, ASST della Valle Olona, Busto Arsizio Hospital, Busto Arsizio, Italy
f Infectious Diseases Clinic, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy
g Infectious Disease Clinic, University Hospital Policlinico, Bari, Italy
h Unit of Infectious Diseases, Careggi Hospital, Firenze, Italy
i Unit of Infectious Diseases, Santa Maria Hospital, Perugia, Italy
⁎Corresponding author.
Keywords : Tenofovir, Hepatitis C virus, Sofosbuvir/ledipasvir
Le texte complet de cet article est disponible en PDF.
Plan
© 2017
Elsevier Masson SAS. Tous droits réservés.
Vol 41 - N° 5
P. e76-e79 - octobre 2017 Retour au numéro
Article précédent
- Acute ischemic gastric ulcer
- Luca Roncati, Antonio Manenti, Emilio Simonini, Alberto Farinetti
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?